Similar results have been demonstrated in primary colon cancers, showing that the CT based-radiomics signature was significantly associated with KRAS/NRAS/BRAF mutations and this approach may be useful for analysis of tumor genotype [54]. This evidence concerns the gene KRAS and colonic neoplasm.